Experience of the COVID-19 Pandemic in the Care of Patients with Predominantly Antibody Deficiencies (PADs)—A Qualitative Study with Perspectives from Both Patients and Nurses
Abstract
:1. Introduction
1.1. Care of PAD Patients
1.2. Rationale of the Study
2. Materials and Methods
2.1. Data Collection
2.2. Data Analysis
3. Results
3.1. Consequences for Managing Everyday Life
“It has been easier to explain, I think, to those around me, but this is how it always is for me.”(fg 1—person with PAD)
“It took quite a long time to find out if I belonged to a risk group and therefore being allowed to receive vaccination early and before others.”(fg 1—person with PAD)
“My patients—many of them—thought that if they contracted COVID-19 they would die, so they were really scared and started to isolate themselves completely.”(fg 2—nurse)
“I think there was a bit of a lack of information actually; I would have liked to have more information from the start.”(fg 2—person with PAD)
“It was quite a long period that we did not have any answers; the first year we did not have any knowledge about what could happen to patients with PAD and which ones could be at risk of becoming severely ill.”(fg 1—nurse)
3.2. Obtaining and Offering Support from Healthcare Services
“I am all alone so it is hard when they reject you…next time I make contact I may have made contact ten times without being allowed to come [to primary care].”(fg 3—person with PAD)
“Then we also got started quite quickly with video visits.”(fg 2—nurse)
4. Discussion
Strengths and Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Public Involvement Statement
Guidelines and Standards Statement
Use of Artificial Intelligence
Acknowledgments
Conflicts of Interest
Abbreviations
PAD | Predominantly antibody deficiencies |
PHAS | Public Health Agency of Sweden |
IEI | Inborn errors of immunity |
CVID | Common variable immunodeficiency |
Ig | Immunoglobulin |
XLA | X-linked agammaglobulin |
HRQoL | Health-related quality of life |
fg | Focus groups |
Appendix A
Appendix B. COREQ Checklist
Topic | Guide Questions | Reported on Page: |
Interviewer | Which author/s conducted the interview or focus group? | 4 |
Credentials | What were the researcher’s credentials? e.g., PhD, MD. | PhD and MD |
Occupation | What was their occupation at the time of the study? | RN, PhD, MD, and PhD student |
Gender | Was the researcher male or female? | Female |
Experience and training | What experience or training did the researcher have? | More than five years |
Relationship established | Was a relationship established prior to the study’s commencement? | No |
Participant knowledge of the interviewer | What did the participants know about the researcher? e.g., personal goals, reasons for conducting the research. | Improving care was described as the main goal |
Interviewer characteristics | What characteristics were reported about the interviewer/facilitator? e.g., bias, assumptions, reasons, interests in the research topic. | 4 and 9 |
Methodological orientation and theory | What methodological orientation was stated to underpin the study? e.g., grounded theory, discourse analysis, ethnography, phenomenology, content analysis. | 4 |
Sampling | How were participants selected? e.g., purposive, convenience, consecutive, snowball. | 4 |
Method of approach | How were participants approached? e.g., face-to-face, telephone, mail, email. | 4 |
Sample size | How many participants were in the study? | 3 |
Non-participation | How many people refused to participate or dropped out? Reasons? | 3 |
Setting of data collection | Where was the data collected? e.g., home, clinic, workplace. | 4 |
Presence of non-participants | Was anyone else present besides the participants and researchers? | 4 |
Description of sample | What are the important characteristics of the sample? e.g., demographic data, date. | 4 and Table 1 and Table 2 (page 3) |
Interview guide | Were questions, prompts and guides provided by the authors? Was it pilot tested? | 4 |
Repeat interviews | Were repeat interviews carried out? If yes, how many? | No |
Audio/visual recording | Did the research use audio or visual recordings to collect the data? | Yes |
Field notes | Were field notes made during and/or after the interview or focus group? | No |
Duration | What was the duration of the interviews or focus group? | 4 |
Data saturation | Was data saturation discussed? | Yes |
Transcripts returned | Were transcripts returned to participants for comments and/or corrections? | No—but the observer summarized the interviews and time for correction was provided |
Number of data coders | How many data coders coded the data? | 2 (page 4) |
Description of the coding tree | Did the authors provide a description of the coding tree? | Yes, Table 3 (page 5) |
Derivation of themes | Were themes identified in advance or derived from the data? | Inductive |
Software | What software, if applicable, was used to manage the data? | Excel spreadsheet |
Participant checking | Did participants provide feedback on the findings? | No |
Quotations presented | Were participant quotations presented to illustrate the themes/findings? Was each quotation identified? e.g., participant number. | Yes |
Consistency between data and findings | Was there consistency between the data presented and the findings? | Yes |
Clarity of major themes | Were major themes clearly presented in the findings? | Described in Table 4 (page 5) |
Clarity of minor themes | Is there a description of diverse cases or a discussion of minor themes? | Yes |
References
- Tegnell, A. The Swedish public health response to COVID-19. Apmis J. Pathol. Microbiol. Immunol. 2021, 129, 320–323. [Google Scholar] [CrossRef] [PubMed]
- Winblad, U.; Swenning, A.-K.; Spangler, D. Soft law and individual responsibility: A review of the Swedish policy response to COVID-19. Health Econ. Policy Law. 2021, 17, 48–61. [Google Scholar] [CrossRef]
- Anwar, A.; Malik, M.; Raees, V.; Anwar, A. Role of Mass Media and Public Health Communications in the COVID-19 Pandemic. Cureus 2020, 12, e10453. [Google Scholar] [CrossRef]
- Bonilla, F.A.; Barlan, I.; Chapel, H.; Costa-Carvalho, B.T.; Cunningham-Rundles, C.; de la Morena, M.T.; Espinosa-Rosales, F.J.; Hammarström, L.; Nonoyama, S.; Quinti, I.; et al. International Consensus Document (ICON): Common Variable Immunodeficiency Disorders. J. Allergy Clin. Immunol. Pract. 2016, 4, 38–59. [Google Scholar] [CrossRef]
- Tangye, S.G.; Al-Herz, W.; Bousfiha, A.; Cunningham-Rundles, C.; Franco, J.L.; Holland, S.M.; Klein, C.; Morio, T.; Oksenhendler, E.; Picard, C.; et al. Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee. J. Clin. Immunol. 2022, 42, 1473–1507. [Google Scholar] [CrossRef] [PubMed]
- Rhim, J.W. Importance of neonatal screening for primary immunodeficiencies. Clin. Exp. Pediatr. 2021, 64, 519–520. [Google Scholar] [CrossRef]
- Baumann, U.; Routes, J.M.; Soler-Palacín, P.; Jolles, S. The Lung in Primary Immunodeficiencies: New Concepts in Infection and Inflammation. Front. Immunol. 2018, 9, 1837. [Google Scholar] [CrossRef] [PubMed]
- Anderson, J.T.; Cowan, J.; Condino-Neto, A.; Levy, D.; Prusty, S. Health-related quality of life in primary immunodeficiencies: Impact of delayed diagnosis and treatment burden. Clin. Immunol. 2022, 236, 108931. [Google Scholar] [CrossRef]
- Hultberg, J.; Ernerudh, J.; Larsson, M.; Nilsdotter-Augustinsson, Å.; Nyström, S. Plasma protein profiling reflects T(H)1-driven immune dysregulation in common variable immunodeficiency. J. Allergy Clin. Immunol. 2020, 146, 417–428. [Google Scholar] [CrossRef]
- Peshko, D.; Kulbachinskaya, E.; Korsunskiy, I.; Kondrikova, E.; Pulvirenti, F.; Quinti, I.; Blyuss, O.; Galvin, A.D.; Munblit, D. Health-Related Quality of Life in Children and Adults with Primary Immunodeficiencies: A Systematic Review and Meta-Analysis. J. Allergy Clin. Immunol. Pract. 2019, 7, 1929–1957.e5. [Google Scholar] [CrossRef]
- Jolles, S.; Orange, J.S.; Gardulf, A.; Stein, M.R.; Shapiro, R.; Borte, M.; Berger, M. Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease. Clin. Exp. Immunol. 2015, 179, 146–160. [Google Scholar] [CrossRef] [PubMed]
- Routes, J.; Costa-Carvalho, B.T.; Grimbacher, B.; Paris, K.; Ochs, H.D.; Filipovich, A.; Hintermeyer, M.; de Melo, K.M.; Workman, S.; Ito, D.; et al. Health-Related Quality of Life and Health Resource Utilization in Patients with Primary Immunodeficiency Disease Prior to and Following 12 Months of Immunoglobulin G Treatment. J. Clin. Immunol. 2016, 36, 450–461. [Google Scholar] [CrossRef] [PubMed]
- Georgina, L.J.; Katharina, S.V.; Duncan, C.; Mark, C.; Anna, S. What Is the Burden of Immunoglobulin Replacement Therapy in Adult Patients With Primary Immunodeficiencies? A Systematic Review. Front. Immunol. 2018, 9, 1308. [Google Scholar] [CrossRef]
- Gardulf, A.; Hammarstrom, L.; Smith, C.I. Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion. Lancet 1991, 338, 162–166. [Google Scholar] [CrossRef]
- Hansen, S. Sammanställning av Resultat från registret 2023-06-31. 2023. Available online: https://pidcare.se/media/zmejdn3i/resultat_pidcare_halv%C3%A5rsredovisning_2023-06-30.pdf (accessed on 30 June 2023).
- Vickers, P.; Gardulf, A.; Warner, A. The role of nurses in recognizing and caring for patients with primary immunodeficiencies. Pharm. Policy Law 2008, 10, 43–50. [Google Scholar]
- Napiórkowska-Baran, K.; Rosada, T.; Więsik-Szewczyk, E.; Ziętkiewicz, M.; Matyja-Bednarczyk, A.; Baranowska, K.; Alska, E.; Tykwińska, M.; Szynkiewicz, E.; Zacniewski, R.; et al. A multicenter survey on the aspects of everyday life in adult patients with primary antibody deficiencies treated with immunoglobulin G replacement during the COVID-19 pandemic. Int. J. Immunopathol. Pharmacol. 2021, 35, 20587384211044344. [Google Scholar] [CrossRef] [PubMed]
- Arroyo-Sanchez, D.; Cabrera-Marante, O.; Laguna-Goya, R.; Almendro-Vazquez, P.; Carretero, O.; Gil-Etayo, F.J.; Suàrez-Fernández, P.; Pérez-Romero, P.; de Frías, E.R.; Serrano, A.; et al. Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency. J. Clin. Immunol. 2022, 42, 240–252. [Google Scholar] [CrossRef]
- Elo, S.; Kyngäs, H. The qualitative content analysis process. J. Adv. Nurs. 2008, 62, 107–115. [Google Scholar] [CrossRef]
- Tong, A.; Sainsbury, P.; Craig, J. Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. Int. J. Qual. Health Care 2007, 19, 349–357. [Google Scholar] [CrossRef]
- Esaiasson, P.; Sohlberg, J.; Ghersetti, M.; Johansson, B. How the coronavirus crisis affects citizen trust in institutions and in unknown others: Evidence from ’the Swedish experiment’. Eur. J. Political-Res. 2021, 60, 748–760. [Google Scholar] [CrossRef]
- Sowers, K.L.; Galantino, M.L. Living with primary immunodeficiency disease during the COVID-19 pandemic. J. Public Health 2022, 30, 2753–2760. [Google Scholar] [CrossRef]
- Folkhälsomyndigheten. När Hände vad Under Pandemin? Available online: https://www.folkhalsomyndigheten.se/smittskydd-beredskap/utbrott/utbrottsarkiv/covid-19-pandemin-2019-2023/nar-hande-vad-under-pandemin/ (accessed on 15 April 2023).
- Ludvigsson, J.F. The first eight months of Sweden’s COVID-19 strategy and the key actions and actors that were involved. Acta Paediatr. 2020, 109, 2459–2471. [Google Scholar] [CrossRef] [PubMed]
- Bauer, P.C. Negative Experiences and Trust: A Causal Analysis of the Effects of Victimization on Generalized Trust. Eur. Sociol. Rev. 2014, 31, 397–417. [Google Scholar] [CrossRef]
- Ingadottir, B.; Bragadottir, B.; Zoëga, S.; Blondal, K.; Jonsdottir, H.; Hafsteinsdottir, E.J.G. Sense of security during COVID-19 isolation improved with better health literacy—A cross-sectional study. Patient Educ. Couns. 2023, 114, 107788. [Google Scholar] [CrossRef] [PubMed]
- Baral, S.; Chandler, R.; Prieto, R.G.; Gupta, S.; Mishra, S.; Kulldorff, M. Leveraging epidemiological principles to evaluate Sweden’s COVID-19 response. Ann. Epidemiol. 2020, 54, 21–26. [Google Scholar] [CrossRef]
- Rana, M.S.; Usman, M.; Alam, M.M.; Tahir, M.; Ikram, A.; Zaidi, S.S.Z. Changes in the prevalence of infectious diseases before and after the COVID-19 pandemic in Pakistan. J. Infect. 2023, 86, 415–416. [Google Scholar] [CrossRef]
- Tull, M.T.; Edmonds, K.A.; Scamaldo, K.M.; Richmond, J.R.; Rose, J.P.; Gratz, K.L. Psychological Outcomes Associated with Stay-at-Home Orders and the Perceived Impact of COVID-19 on Daily Life. Psychiatry Res. 2020, 289, 113098. [Google Scholar] [CrossRef]
- Lee, J.; Wilson, J.; Oosterhoff, B.; Shook, N.J. Self-quarantining, social distancing, and mental health during the COVID-19 pandemic: A multi wave, longitudinal investigation. PLoS ONE 2024, 19, e0298461. [Google Scholar] [CrossRef]
- Keswani, A.; Brooks, J.P.; Khoury, P. The Future of Telehealth in Allergy and Immunology Training. J. Allergy Clin. Immunol. Pract. 2020, 8, 2135–2141. [Google Scholar] [CrossRef]
- Yelverton, V.; Gass, S.-J.; Amoatika, D.; Cooke, C.; Ostermann, J.; Natafgi, N.; Hair, N.L.; Olatosi, B.; Owens, O.L.; Qiao, S.; et al. The Future of Telehealth in Human Immunodeficiency Virus Care: A Qualitative Study of Patient and Provider Perspectives in South Carolina. AIDS Patient Care STDs 2023, 37, 459–468. [Google Scholar] [CrossRef]
- Loeb, A.E.; Rao, S.S.; Ficke, J.R.; Morris, C.D.; Riley, L.H.I.; Levin, A.S. Departmental Experience and Lessons Learned With Accelerated Introduction of Telemedicine During the COVID-19 Crisis. JAAOS J. Am. Acad. Orthop. Surg. 2020, 28, e469–e476. [Google Scholar] [CrossRef] [PubMed]
- Myndigheten för Vård och Omsorg 2014. Vården ur Patienternas Perspektiv. Available online: https://www.vardanalys.se/rapporter/varden-ur-patienternas-perspektiv/ (accessed on 30 March 2023).
- Jansen, D.L.; Heijmans, M.; Rijken, M. Individual care plans for chronically ill patients within primary care in the Netherlands: Dissemination and associations with patient characteristics and patient-perceived quality of care. Scand. J. Prim. Health Care. 2015, 33, 100–106. [Google Scholar] [CrossRef] [PubMed]
- Quinti, L.; Pulvirenti, F. Health-Related Quality of Life and Patients’ Empowerment in the Health Care of Primary Immune Deficiencies. J. Clin. Immunol. 2017, 37, 615–616. [Google Scholar] [CrossRef]
- Lincoln, Y.S.; Guba, E.G. Naturalistic Inquiry; SAGE Publications Inc.: Newbury Park, CA, USA, 1985. [Google Scholar]
- Folhälsomyndigheten. Pandemiberedskap. Hur vi Förbereder Oss—Ett Kunskapsunderlag. Stockholm: Folkhälsomyndigheten. 2019. Available online: https://www.folkhalsomyndigheten.se/contentassets/b6cce03c4d0e4e7ca3c9841bd96e6b3a/pandemiberedskap-hur-vi-forbereder-oss-19074-1.pdf/ (accessed on 7 October 2021).
- Regeringen. Strategi Med Anledning av det Nya Coronaviruset. 2020. Available online: https://www.regeringen.se/regeringens-politik/regeringens-arbete-medcoronapandemin/strategi-med-anledning-av-det-nya-coronaviruset/ (accessed on 7 October 2021).
- Ludvigsson, J. Så har Sveriges Coronastrategi Framstått Under Åtta Månader. 2020. Available online: https://lakartidningen.se/klinik-och-vetenskap-1/kommentar/2020/11/sa-harsveriges-coronastrategi-framstatt-under-atta-manader/ (accessed on 7 October 2021).
- Milne, R. Anders Tegnell and the Swedish Covid Experiment. 2020. Available online: https://www.ft.com/content/5cc92d45-fbdb-43b7-9c66-26501693a371/ (accessed on 7 October 2021).
- Dahlström, C.; Lindvall, J. Sverige og Covid-19-Krisen”, Bilaga 4 i Håndteringen af Covid-19 i Foråret 2020. Rapport Afgivet af den af Folketingets Udvalg for Forretningsordenen Nedsatte Udredningsgruppe Vedr. Håndteringen af Covid-19. 2021. Available online: https://www.ft.dk/-/media/sites/ft/pdf/publikationer/haandtering-af-covid19-foraar-2020.pdf (accessed on 7 October 2021).
- Pashakhanlou, A.H. Sweden’s coronavirus strategy: The Public Health Agency and the sites of controversy. World Med. Health Policy 2021, 14, 507–527. [Google Scholar] [CrossRef] [PubMed]
Total Number | Age Years Median (Range) | Gender | Cohabitant/Single | Employment | COVID-19 | Vaccine Uptake |
---|---|---|---|---|---|---|
12 | 59 (28–83) | 7 men 5 women | 10 cohabitant 2 single | 6 working 1 disability 5 retired | 7 confirmed (1 of which in patient care) 5 no symtoms | 11 |
Total Number | Age Years Median (Range) | Gender | Years of Experience (Range) |
---|---|---|---|
12 | 57 (43–68) | Women only | 14 (1–25) |
Meaningful Unit | Condensation | Subcategories | Generic Categories | Main Category |
---|---|---|---|---|
“I look back on the pandemic then i felt good purely so, then i thought it was hard mentally to sit at home and not see anyone—but just for the immunodeficiency it went great” | Infection-free but mentally hard to sit at home | Social isolations | Consequences for managing everyday life | From crisis to new orientation |
Main Category | Generic Category | Subcategories |
---|---|---|
From crisis to new orientation | Consequences for managing everyday life |
|
Obtaining and offering support from the healthcare service |
|
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Fust, R.; Nyström, S.; Åkerlind, B.; Nilsdotter-Augustinsson, Å.; Petersson, C. Experience of the COVID-19 Pandemic in the Care of Patients with Predominantly Antibody Deficiencies (PADs)—A Qualitative Study with Perspectives from Both Patients and Nurses. Nurs. Rep. 2025, 15, 104. https://doi.org/10.3390/nursrep15030104
Fust R, Nyström S, Åkerlind B, Nilsdotter-Augustinsson Å, Petersson C. Experience of the COVID-19 Pandemic in the Care of Patients with Predominantly Antibody Deficiencies (PADs)—A Qualitative Study with Perspectives from Both Patients and Nurses. Nursing Reports. 2025; 15(3):104. https://doi.org/10.3390/nursrep15030104
Chicago/Turabian StyleFust, Ramona, Sofia Nyström, Britt Åkerlind, Åsa Nilsdotter-Augustinsson, and Christina Petersson. 2025. "Experience of the COVID-19 Pandemic in the Care of Patients with Predominantly Antibody Deficiencies (PADs)—A Qualitative Study with Perspectives from Both Patients and Nurses" Nursing Reports 15, no. 3: 104. https://doi.org/10.3390/nursrep15030104
APA StyleFust, R., Nyström, S., Åkerlind, B., Nilsdotter-Augustinsson, Å., & Petersson, C. (2025). Experience of the COVID-19 Pandemic in the Care of Patients with Predominantly Antibody Deficiencies (PADs)—A Qualitative Study with Perspectives from Both Patients and Nurses. Nursing Reports, 15(3), 104. https://doi.org/10.3390/nursrep15030104